<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome (AS)</z:e> is a neurogenetic disorder caused by the lack of functional ubiquitin-protein ligase E3A (UBE3A) that acts as an E3 ligase in the ubiquitin-proteosomal degradation pathway and/or as a transcriptional coactivator </plain></SENT>
<SENT sid="1" pm="."><plain>Besides neurological deficit, <z:hpo ids='HP_0001010'>hypopigmentation</z:hpo> is another phenotype associated with AS patients currently attributed to the hemizygosity of the type II oculocutaneous <z:hpo ids='HP_0001022'>albinism</z:hpo> (OCA2) gene </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show that the melanocortin-1-receptor (MC1R) is down-regulated in the skin of the Ube3a((-/-)) mice </plain></SENT>
<SENT sid="3" pm="."><plain>Luciferase-reporter assay shows that UBE3A is able to induce MC1R promoter activity </plain></SENT>
<SENT sid="4" pm="."><plain>Using chromatin immunoprecipitation assay, Ube3a was observed to be physically associated with the Mc1r promoter </plain></SENT>
<SENT sid="5" pm="."><plain>Deletion of the E box/SP1 element in the MC1R minimal promoter abolishes the ability of UBE3A to elevate MC1R promoter-luciferase reporter activity </plain></SENT>
<SENT sid="6" pm="."><plain>Ube3a((-/-)) mice also show relative skin <z:hpo ids='HP_0001010'>hypopigmentation</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>These results demonstrate that UBE3A plays a role in MC1R transcriptional regulation which can contribute to the development of <z:hpo ids='HP_0001010'>hypopigmentation</z:hpo> in AS patients </plain></SENT>
</text></document>